OrthoPediatrics signs exclusive U.S. distribution deal with OSSIO for OSSIOfiber bio‑integrative, metal‑free fixation implants
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $204.73M | $148.73M | $122.29M | $98.05M | $71.08M | $72.55M | $57.56M | $45.62M |
| Cost of Revenue | $56.13M | $37.48M | $31.63M | $24.65M | $16.05M | $17.93M | $14.88M | $11.17M |
| Gross Profit | $148.60M | $111.25M | $90.66M | $73.40M | $55.03M | $54.62M | $42.68M | $34.45M |
| Gross Margin | 72.58% | 74.80% | 74.14% | 74.86% | 77.42% | 75.28% | 74.15% | 75.52% |
| Operating Expenses | $178.12M | $138.00M | $116.06M | $91.43M | $81.79M | $63.70M | $52.23M | $40.92M |
| Operating Income | $-29.52M | $-26.75M | $-25.40M | $-18.02M | $-26.75M | $-9.08M | $-9.55M | $-6.47M |
| Operating Margin | -14.42% | -17.99% | -20.77% | -18.38% | -37.64% | -12.51% | -16.60% | -14.19% |
| Net Income | $-37.82M | $-20.97M | $1.26M | $-16.26M | $-32.94M | $-13.73M | $-12.03M | $-8.93M |
| Net Margin | -18.47% | -14.10% | 1.03% | -16.58% | -46.35% | -18.93% | -20.89% | -19.58% |
| EPS (Basic) | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-1.18 | $-0.96 | $-1.85 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |